TRX — Tissue Regenix Share News
0.000.00%
HealthcareSpeculativeMicro Cap
- £5.18m
- £12.00m
- $28.65m
Brief: Tissue Regenix Group Says Jay Lecoque Appointed As Executive Chairman
Half-Year Trading Update and Notice of Results
Board Changes
Brief: Tissue Regenix Appoints Brandon Largent As Interim CFO
Directorate Change
Grant of share options
Posting of Annual Report & Notice of AGM
Final results for the year ended 31 December 2024
CE & UKCA certification for OrthoPure® XT
Brief: Tissue Regenix Group Terminates Strategic Review, No Longer In Offer Period
Conclusion of Strategic Review & Offer Period
Brief: Tissue Regenix Group Granted European Patent For Decellularisation Technology
European patent granted
Brief: Tissue Regenix Continues To Execute 4s Strategy
Company update
Brief: Tissue Regenix Group Sees Adj EBITDA Profit Above Expectations For Year
Full year trading update
Holding(s) in Company
Holding(s) in Company